Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide
暂无分享,去创建一个
Nader Rifai | Christopher P Cannon | David A Morrow | E. Antman | M. Sabatine | E. Braunwald | C. Cannon | N. Rifai | D. Morrow | S. Murphy | J. D. de Lemos | C. McCabe | C. Gibson | Elliott M Antman | James A de Lemos | Marc S Sabatine | Sabina A Murphy | C Michael Gibson | Eugene Braunwald | Carolyn McCabe | C. Gibson | C. Mccabe
[1] E. Antman,et al. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy , 1998 .
[2] M. Sabatine,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.
[3] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[4] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.
[5] Eorge,et al. CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES , 2000 .
[6] P. Ridker,et al. C-reactive protein, inflammation, and coronary risk. , 2000, The Medical clinics of North America.
[7] Pedro Lozano. Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.
[8] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[9] A. Skene,et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. , 2000, Circulation.
[10] Jack H. Ladenson,et al. Cardiac Troponin I A Marker With High Specificity for Cardiac Injury , 1993, Circulation.
[11] E. Braunwald,et al. Unstable angina: an etiologic approach to management. , 1998, Circulation.
[12] C. Visser,et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? , 1999, Circulation.
[13] E. Braunwald,et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. , 2001, JAMA.